IPHA | Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Innate Pharma SA (IPHA) on Behalf of Investors

Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Innate Pharma SA (“Innate” or the “Company”) (NASDAQ: IPHA) investors concerning the Company’s possible violations of the federal securities laws.If you suffered a loss on your Innate investments or would like […]